The laboratory information management system (LIMS) landscape in 2024 is a dynamic one, driven by accelerating advancements in technology and evolving industry needs. This article shares the four key trends.
- What Proposed Plasmid DNA Standards Say For GMP/Non-GMP Production
- Drugging The Undruggable: Strategies And Future Directions
- 8 Key Takeaways Of The Proposed FDA Modernization Act 3.0
- Shocking! Biotech Facilities Don't Maintain Themselves
- The Future of Rare Diseases with The Jackson Laboratory’s Rare Disease Translational Center's Cat Lutz
- Exploring Biolistic Particle Delivery Systems
- Comparability Considerations For mRNA Product Development
- FDA’s Updated Guidance On Human Genome Editing: New Implications & Remaining Questions
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Compatible Platforms For Microbial Identification
Reduce the time-to-results for microbial identification by taking advantage of the shorter run cycle and off-instrument data analysis provided by this optimized and validated workflow.
-
Molecular Weight Confirmation For Length, Integrity And Impurity Analysis Of A 70-Mer Oligonucleotide
Explore a workflow used to determine the molecular weight and analyze the purity of a 70-mer DNA sequence with a 3’ dT overhang.
-
Achieve Fast And Efficient Isolation Of Exosomes From Stem Cells
Review this demonstration of a bioreactor and bioreactor system combination used to isolate exosomes after culturing human adipose-derived stem cells in suspension on microcarriers.
-
Successful Filter Integrity Testing Using The WIT Method
Explore the collected best methods/practices to give filter end users the best possible chance of performing a successful water intrusion test.
-
Infectious Diseases – 2018-2023 Global Clinical Trial Landscape
Gain in-depth insights into infectious diseases-based clinical trials and be better informed about trends, regional disparities, technological advancements, and financing dynamics.
-
Monitoring Industry Contamination Down To Single Particle Level
Examine the benefit of using fluoropolymer film bags for the handling and storage of high value oligonucleotides- based payloads.
-
HEK293T Cell Expansion Protocol Using A Hollow-Fiber Bioreactor System
Explore the use of a hollow-fiber bioreactor (HFB) system for the automated expansion of HEK293T cells and a protocol used to help users of the system.
-
Determining RNA Integrity And Purity By Capillary Gel Electrophoresis
To ensure mRNA product quality, it's important to confirm the integrity of the RNA. Examine the results of a study challenging the performance of the CGE method in assessing mRNA integrity and purity.
-
AAV Production In Suspension HEK293 Cells With Single-Use Bioreactors
Explore how we expanded HEK293/HEK293T suspension cells from small cell culture (20 mL) in shake flasks up to a 10 L culture in a benchtop Xcellerex™ XDR-10 single-use bioreactor system.
-
Optimizing Accuracy Performance On A Beckman Coulter Biomek
Explore an approach for optimizing pipetting accuracy on a Beckman Coulter Biomek liquid handler using MVS® measurement information.
NEWSLETTER ARCHIVE
- 03.18.24 -- Bringing Therapies To Patients With Speed And Confidence
- 03.18.24 -- Reducing Batch-To-Batch Variation In Cell Therapy Manufacturing
- 03.14.24 -- Explore Revolutionary Research Shaping Medicine
- 03.14.24 -- mRNA: Challenges & Opportunities For Scale-Out, Optimization
- 03.13.24 -- Regulatory & GMP Manufacturing Insights Into mRNA-LNP Drug Products
- Rare Disease Day 2024
- Video Clips From Cell & Gene Live: 2024 Regulatory Outlook With FDA's Dr. Peter Marks And Dr. Nicole Verdun
- Inside Cell & Gene Live “How To Reduce Batch-To-Batch Variation In Cell Therapy Manufacturing”
- Mass General Cancer Center’s Dr. Genevieve Boland on Amtagvi Approval
- Inside Cell & Gene Live “2024 Regulatory Outlook With FDA’s Dr. Peter Marks And Dr. Nicole Verdun”
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections